GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Net Margin %

Vectus Biosystems (ASX:VBS) Net Margin %

: -117,800.00% (As of Dec. 2023)
View and export this data going back to 2016. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Vectus Biosystems's Net Income for the six months ended in Dec. 2023 was A$-1.18 Mil. Vectus Biosystems's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, Vectus Biosystems's net margin for the quarter that ended in Dec. 2023 was -117,800.00%.

The historical rank and industry rank for Vectus Biosystems's Net Margin % or its related term are showing as below:

ASX:VBS' s Net Margin % Range Over the Past 10 Years
Min: -248800   Med: -63233.33   Max: -63233.33
Current: -248800


ASX:VBS's Net Margin % is ranked worse than
99.03% of 1026 companies
in the Biotechnology industry
Industry Median: -163.08 vs ASX:VBS: -248800.00

Vectus Biosystems Net Margin % Historical Data

The historical data trend for Vectus Biosystems's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Premium Member Only Premium Member Only Premium Member Only - - - - -

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -23,766.67 - -117,800.00

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems Net Margin % Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Net Margin % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Net Margin % falls into.



Vectus Biosystems Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Vectus Biosystems's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-3.449/0
= %

Vectus Biosystems's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-1.178/0.001
=-117,800.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems  (ASX:VBS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Vectus Biosystems Net Margin % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines